Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. Mount Sinai Physician’s Channel will show you some of the innovative procedures, developments in patient care, and complex cases that are being handled in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field.
Featured Items
New Content
Consensus Defines Postpartum Psychosis as Distinct Clinical Entity
An international panel of leading experts on women’s mental health is recommending that postpartum psychosis be recognized as a distinct category of mental illness and classified accordingly within standardized medical coding systems.
Mount Sinai Studies Reveal Molecular Gaps in Living vs. Postmortem Brain
Two new research papers from the landmark Living Brain Project at Mount Sinai present what is, by several metrics, the largest investigation ever performed of the biology of the living human brain
Specialty Reports September 2025
Mount Sinai Health System is pleased to present these reports covering our groundbreaking research and compassionate, equitable, and safe patient care.
New IL-23 Inhibitors Expand Treatment Options for Crohn’s Disease
The U.S. Food and Drug Administration has approved two new medications for Crohn’s disease, following the results of successful multisite clinical trials conducted in part at the Icahn School of Medicine at Mount Sinai. The therapies, ...
Same-Day Discharge of Colorectal Surgery Patients Is Gradually Taking Shape at Mount Sinai
A rigorous protocol that Mount Sinai colorectal surgeons have methodically developed is showing highly encouraging results that generally support the feasibility and safety of same-day colorectal surgery discharge in a carefully controlled environment.
Probing the Power of Hepatocyte Regeneration to Treat Chronic Liver Disease
While scientists have made significant strides in detailing the mechanisms of regeneration in healthy livers, less understood is what happens in an ailing liver. In chronic diseases such as MASH, hepatocytes are less able to regenerate ...
A New Hub for Liver Research Tackles Its First Investigations
Mount Sinai's newly launched Institute for Liver Research has funded its first two pilot projects, chosen from among 11 applications submitted by basic, translational, or clinical research teams, and awarded one-year grants of $30,000 ...
The Brookdale Department has created flexible programs allowing doctors to pursue training in their chosen specialties, while also providing opportunities for professional development in geriatrics and palliative medicine.
Biomarkers May Help Quest for a Link Between Apnea and Alzheimer's
Links between obstructive sleep apnea and Alzheimer’s disease (AD) have long been thought to exist, but the long time horizon for Alzheimer's has been a barrier to investigation. Mount Sinai has now launched a study to assess whether patients ...
AI Speeds Search for Therapies That Fight Adenocarcinoma
Mount Sinai researchers are assessing a platform that can conduct in silico scans of millions of potential drugs each day to identify candidates for testing and validation. The goal is to facilitate the identification of safe, effective ...
Mount Sinai Secures $8M to Boost Drug Discovery for CADASIL and Brain Disorders
The transformational grant will launch a new center led by Dr. Fanny Elahi to pursue treatments for understudied neurovascular diseases
Peter Morgenstern, MD was the PI for Mount Sinai, an enrolling site for the multi-institutional PENS trial.
Mount Sinai Launches Cardiac Catheterization Artificial Intelligence Research Lab
New AI research lab at The Mount Sinai Hospital aims to transform patient care for complex heart procedures
Coronary Calcium Score Identifies Plaque in Patients with Non-Typical Symptoms by Age and Sex
Findings included that the sensitivity of a CAC score >0 for detecting coronary plaque varies by age and sex. In patients under 55, a score of 0 poorly excludes plaque, while it is more reliable in older adults. Overall, CAC scores perform ...
Mount Sinai Study Confirms Safety of Prefrontal Biopsies During DBS
Mount Sinai findings address unmet need for collecting living human brain tissue to advance medical research
Study Challenges Beta Blocker Use Post-MI, Especially in Women
Landmark study challenges the 40-year-old standard of care, and may change clinical practice to eliminate negative side effects